4.6 Article

Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations

期刊

JOURNAL OF CLINICAL EPIDEMIOLOGY
卷 66, 期 9, 页码 964-972

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinepi.2013.02.011

关键词

SSRI exposure; Prescription databases; Pregnancy; Validity; Misclassification; MoBa

资金

  1. Norwegian Ministry of Health
  2. Ministry of Education and Research
  3. NIH/NIEHS [NO-ES-75558]
  4. NIH/NINDS [1 UO1 NS 047537-01]
  5. Norwegian Research Council/FUGE [151918/S10]
  6. Norwegian Institute of Public Health

向作者/读者索取更多资源

Objectives: To assess the impact of exposure misclassification on risk associations when using prescription databases as the source for drug exposure in pregnancy by applying results from a validation analysis of exposure classification. Study Design and Setting: Linkage of data on 27,656 participants in the Norwegian Mother and Child Cohort Study (MoBa) with the Norwegian Prescription Database (NorPD). Exposure to selective serotonin reuptake inhibitors (SSRIs) was defined by dispensed drugs during pregnancy including different time windows before pregnancy. The validity of NorPD data was estimated using self-reported use in MoBa as the reference standard. We applied the results from the validation analysis on data from a Nordic study on SSRI use in pregnancy and risk of persistent pulmonary hypertension in the newborn. Results: Sensitivity increased and specificity decreased when the time window in NorPD was expanded before pregnancy. Using the same time window as in the Nordic study (+90 days before pregnancy), for use in early pregnancy, the odds ratio (OR) corrected for misclassification was 2.6 compared with the OR of 1.6 in the Nordic study. Conclusion: Expansion of the time window to include intervals before pregnancy can lead to lower specificity and underestimation of risk associations. (C) 2013 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Obstetrics & Gynecology

Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study

A. Lupattelli, M. Mahic, M. Handal, E. Ystrom, T. Reichborn-Kjennerud, H. Nordeng

Summary: Children exposed to SSRI/SNRI treatment during pregnancy do not have significantly higher risk of ADHD compared to those who were untreated or discontinued treatment, but there is an elevated risk at 7-9 years old. Maternal depression/anxiety before pregnancy is independently associated with child ADHD.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Article Medicine, General & Internal

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)

Lars T. Fadnes, Christer Frode Aas, Jorn Henrik Vold, Rafael Alexander Leiva, Christian Ohldieck, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jorgen Lygren, Olav Dalgard, Peter Vickerman, Havard Midgard, Else-Marie Loberg, Kjell Arne Johansson

Summary: This study found that integrated treatment for chronic HCV infection among people who inject drugs was more effective in terms of time-to-treatment initiation and achieving sustained virologic response compared to standard treatment. It also showed comparable SVR rates among those who initiated treatment. Scaling up integrated treatment models could be crucial in the elimination of HCV.

PLOS MEDICINE (2021)

Article Health Care Sciences & Services

PriSUD-Nordic-Diagnosing and Treating Substance Use Disorders in the Prison Population: Protocol for a Mixed Methods Study

Anne Bukten, Nicoline Toresen Lokdam, Ingeborg Skjaervo, Thomas Ugelvik, Svetlana Skurtveit, Roman Gabrhelik, Torbjorn Skardhamar, Ingunn Olea Lund, Ingrid Amalia Havnes, Eline Borger Rognli, Zheng Chang, Seena Fazel, Christine Friestad, Morten Hesse, Johan Lothe, Gerhard Ploeg, Anja J. E. Dirkzwager, Thomas Clausen, Christian Tjagvad, Marianne Riksheim Stavseth

Summary: The PriSUD-Nordic project aims to investigate the epidemiology and lived experiences of people with substance use disorders in the Nordic prison population, with the goal of contributing to better mental and physical health, improved quality of life, and increased life expectancies for this population.

JMIR RESEARCH PROTOCOLS (2022)

Article Substance Abuse

Parental Risk Constellations and Future Alcohol Use Disorder (AUD) in Offspring: A Combined HUNT Survey and Health Registries Study

Jasmina Burdzovic Andreas, Fartein Ask Torvik, Eivind Ystrom, Svetlana Skurtveit, Marte Handal, Priscilla Martinez, Anne-Marie Laslett, Ingunn Olea Lund

Summary: This study examined the risk of developing future alcohol use disorder (AUD) among offspring from families with different combinations of parental risk factors. The results showed that offspring from families characterized by weekly binge drinking, low education, and poor mental health in parents were more likely to develop AUD, even after adjusting for covariates. This suggests that parental drinking patterns, along with additional risk factors like mental health and education, can significantly impact the risk of AUD in offspring.

PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2022)

Article Pharmacology & Pharmacy

Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020

Mikkel Hojlund, Larus S. Gudmundsson, Jacob H. Andersen, Leena K. Saastamoinen, Helga Zoega, Svetlana O. Skurtveit, Jonas W. Wastesson, Jesper Hallas, Anton Pottegard

Summary: The use of benzodiazepines and related drugs has decreased in the Nordic countries from 2004 to 2020, with significant differences between countries. Despite warnings, benzodiazepines are still commonly used in the older population.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2023)

Article Psychology, Developmental

Killing pain?: a population-based registry study of the use of prescription analgesics, anxiolytics, and hypnotics among all children, adolescents and young adults in Norway from 2004 to 2019

Helle Stangeland, Marte Handal, Svetlana Ondrasova Skurtveit, Helene Flood Aakvaag, Grete Dyb, Tore Wentzel-Larsen, Monica Baumann-Larsen, John Anker Zwart, Kjersti Storheim, Synne Oien Stensland

Summary: This study investigated the trends in prescription drug use among children, adolescents, and young adults over the past 15 years. The study found that the use of prescription drugs was low in children and adolescents, but increased with age in adolescents and young adults, particularly for analgesics and drugs with higher potential for misuse. Additionally, females overall used more prescription drugs than their male peers.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2023)

Article Substance Abuse

Individuals Dying of Overdoses Related to Pharmaceutical Opioids Differ from Individuals Dying of Overdoses Related to Other Substances: A Population-Based Register Study

Svetlana Skurtveit, Ingvild Odsbu, Linn Gjersing, Marte Handal, Torgeir Gilje Lid, Thomas Clausen, Aleksi Hamina

Summary: This study investigated the differences in characteristics between individuals who died from pharmaceutical opioid (PO) overdoses and those who died from other types of overdoses. The findings revealed that individuals who died from PO overdoses were typically older, more often women, had a higher prevalence of chronic pain, and used higher doses of prescription opioids compared to those who died from other types of overdoses. These differences highlight the need for tailored prevention strategies.

EUROPEAN ADDICTION RESEARCH (2022)

Article Clinical Neurology

Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia

Mikael Tiger, Rikke Wesselhoeft, Par Karlsson, Marte Handal, Mette Bliddal, Carolyn E. Cesta, Svetlana Skurtveit, Johan Reutfors

Summary: The study found that there was an increase in the utilization of antidepressants, anxiolytics, and hypnotics in Denmark, Norway, and Sweden during the COVID-19 pandemic in 2020. The utilization of antidepressants increased between 13.5% and 31.3% in Denmark and decreased by 16.7% in Swedish youths. There was a general increase in the utilization of other anxiolytics and hypnotics in all countries at the end of 2020. These findings may indicate medication stockpiling and an increase in symptoms of depression, anxiety, and sleep disturbances.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Article Substance Abuse

Morbidity through 3 Years of Age in Children of Women Using Methamphetamine during Pregnancy: A National Registry Study

Roman Gabrhelik, Svetlana Skurtveit, Blanka Nechanska, Viktor Mravcik, Marte Handal

Summary: This study compares the morbidity rates of children with prenatal methamphetamine (MA) and opioid exposure to those without exposure. The results show that children prenatally exposed to MA and opioids have higher hospitalization rates, diagnosis rates, and longer hospital stays compared to non-exposed children. They also have an increased risk of infectious and parasitic diseases and injuries.

EUROPEAN ADDICTION RESEARCH (2023)

Article Substance Abuse

Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway

Gabriela Rolova, Desiree Eide, Roman Gabrhelik, Ingvild Odsbu, Thomas Clausen, Svetlana Skurtveit

Summary: This study examines the physical morbidity in two national cohorts of opioid agonist treatment (OAT) patients, focusing on gender differences. Women in OAT have a significantly higher prevalence of physical diseases, especially genitourinary diseases and neoplasms. Injuries/external causes and infectious/parasitic diseases are common in both women and men, with viral hepatitis accounting for over half of infectious morbidity in both cohorts.

SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2023)

Article Substance Abuse

Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study

Desiree Eide, Svetlana Skurtveit, Thomas Clausen, Morten Hesse, Viktor Mravcik, Blanka Nechanska, Gabriela Rolova, Birgitte Thylstrup, Christian Tjagvad, Abdu Kedir Seid, Ingvild Odsbu, Roman Gabrhelik

Summary: This study aimed to describe non-overdose causes of death among opioid maintenance treatment (OMT) patients in Czechia, Denmark, and Norway, and explore the associations with age and gender. The leading non-overdose causes of death varied across the cohorts, with accidents in Czechia and Denmark, and neoplasms in Norway. Cardiovascular deaths were highest in Czechia, particularly among women in OMT. These findings suggest the importance of screening and preventive health initiatives tailored to the demographic characteristics of OMT patients in different settings.

EUROPEAN ADDICTION RESEARCH (2023)

暂无数据